Page results
-
UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
-
A UCLH and UCL study has identified how a subset of immune cells are activated to kill cancerous cells, a finding in mice which could hold the key to new powerful therapies against cancer.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
File results
-
FOI/2024/0703 - Neurofibromatosis type 1 treatment/ volume of medication dispensed
-
FOI/2024/0704 - Contingencies to support visitors/ patients/ contractors witnessing a distressing event
-
FOI/2024/0716 - Toxicological screening/ testing/ training and information to patients
-
FOI/2024/0718 - Mental health/ electronic health records software/ dermatology screening/ imaging services/ medical devices for wound care
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0727 - Clinical photography solution contract/ spend
-
FOI/2024/0740 - A&E tooth decay admissions for 2021/22, 2022/23 and 2023/24
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details
-
FOI/2024/0750 - Spend on law firms for services related to maternity and neonatal care 2021-2023
-
FOI/2024/0776 - Buildings used by the Trust which still contain asbestos